developed for VSV serodiagnosis. [3] [4] [5] The performance of these procedures using field origin sera submitted for diagnostic purposes has been reported. 3, 5 There is little information, however, regarding the comparative performance of the CF, SN, cELISA, and mcELISA procedures under temporally defined conditions of experimental VSV infection. This study was performed to permit that comparison.
Six VSV-seronegative calves (130 kg) and 3 ponies (180 kg) were housed individually under biocontainment conditions. All 6 calves and 2 of the ponies were infected with VSV-NJ by applying 10 5.0 TCID 50 of virus to each animal's superficially scarified tongue following induction of general anesthesia. The third pony received VSV-IN 1 in the same manner. Serum samples and nasal and oral cavity swabs for virus isolation were collected daily for 14 days postinoculation and at weekly intervals thereafter. 1 All sera were evaluated using each serodiagnostic procedure. 2, 4, 5 Swabs were processed as described for determination of infectivity. 1 All animals were reexposed to 10 5.0 TCID 50 of VSV when each had returned to a VSV-IgM seronegative status (titer < 2.5) with a minimal or undetectable CF titer (< 5). Depending on the animal, reexposure thus occurred between 49 and 77 days after the first inoculation. Two of the calves and Table 1 . Virologic and mean serologic responses of 4 calves and 1 pony experimentally infected with vesicular stomatitis virus (VW) and subsequently challenged with serotypically homologous VSV.* * Titers considered indicative of seronegative status: complement fixation (CF), < 5; IgM ELISA (mcELISA), < 2.5; serum neutralization (SN), < 8; competitive ELISA (cELISA), < 50%. ND = not determined. End point SN titers are not determined diagnostically past 1:256 because that level is considered strongly positive and continued analysis is of little informative or predictive value.
† Second exposure to VSV occurred 49-77 days following first exposure. 329 Table 2 . Virologic and mean serologic responses of 2 calves and 2 ponies experimentally infected with vesicular stomatitis virus (VSV) and subsequently challenged with serotypically heterologous VSV.* * Titers considered indicative of seronegative status: complement fixation (CF'), < 5; IgM ELISA (mcELISA), < 2.5; serum neutralization (SN), < 8; competitive ELISA (cELISA), < 50%. ND = not determined.
† Second exposure to VSV occurred 49-77 days following first exposure.
1 of the VSV-NJ-exposed ponies were inoculated with VSV-IN, for the second exposure (heterologous reexposure). The VSV-IN,-exposed pony was inoculated with VSV-NJ. The remaining 4 calves and 1 pony were reexposed to VSV-NJ (homologous virus reexposure). Sera and virus isolation specimens were collected and tested as before. Virus isolation and comparative serologic data are presented in Table 1 (homologous reexposure) and Table 2 (heterologous reexposure). Animal responses were remarkably similar between species. Responses varied primarily according to whether the reexposure was heterologous or homologous. Recoverable infectivity ceased by 6-7 days following first virus exposure in all animals. Animals reexposed to the homologous serotype of VSV exhibited no recoverable infectivity following reexposure, but those reexposed to a seratypically heterologous VSV did shed heterologous virus for a brief interval (2-4 days) following the second inoculation. Only the oral cavity swabs yielded recoverable virus; nasal cavity swabs did not on any occasion yield VSV.
All animals exhibited clinical signs of VS and mounted serotype-specific CF, IgM (mcELISA), SN, and cELISA responses following initial virus exposure. Positive IgM and cELISA responses consistently appeared 1-2 days prior to SN responses, which in turn appeared either the same day as or 1-2 days prior to CF test seroconversion (Table 1) . All animals reverted to an IgM-seronegative status (< 2.5) within 49 days postexposure, although positive CF titers lingered for at least 56 and usually up to 63-70 days after infection. These results were irrespective of animal species or serotype of infecting virus. All animals reexposed to the homologous serotype VSV did not respond by any of the diagnostic se-rologic measures used in this study following the second exposure. The SN and cELISA titers remained elevated as expected, IgM titers remained negative, and CF titers slowly continued to recede. These findings, coupled with the absence of recoverable infectivity following reexposure, indicate a high level of serotype-specific immunity. In contrast, all animals exposed a second time, but to the heterologous serotype of VSV, were susceptible to reinfection with that virus ( Table  2 ). Modest anamnestic CF and IgM titers appeared to the serotype of VSV initially administered, and initial serotype VSV SN and cELISA responses were, as expected, maintained at a high level. These animals also seroconverted to the heterologous serotype of VSV administered during reexposure by developing heterologous serotype-specific CF, IgM, and SN responses. By all measures, these heterologous serotypic responses appeared simultaneously about 6 days after reexposure ( Table 2) .
The National Veterinary Services Laboratories is now using the VSV cELISA in conjunction with the SN procedure for initial serodiagnostic screening purposes. 3,4 However, the cELISA, like the SN test, does not indicate the recency of a VSV infection. The CF test has traditionally been used for that purpose. 1 The mcELISA reported here detected VSV seroconversion as early or earlier than did the CF test and reverted to negative levels more quickly during convalescence than did the CF test. The mcELISA, as recently reported elsewhere, is also more sensitive, more economical, less prone to nonspecific reactions, and faster to perform than the CF test. 3 Consequently, the VSV mcELISA may replace the CF procedure as the method of choice for detecting recent bovine and equine VSV infections.
Pyogranulomatous encephalitis associated with an unidentified Sarcocystis neurona-like organism in a horse
A. N. Hamir, T. C. Gerros, J. P. Dubey
Equine protozoal myelocephalitis (EPM) is one of the most common neurologic diseases of the horse. 1,4,5 Sarcocystis neurona has been found associated with EPM lesions in the central nervous system of horses in the USA. 1 Recently, another protozoan parasite, Neospora caninum, an organism related to Toxoplasma gondii and S. neurona, was found in a horse with EPM-like disease. 6 Here, we describe an unusual case of EPM with severe encephalitis characterized by necrohemorrhagic granulomatous inflammation associated with the presence of an unidentified S. neurona-like organism in the vascular endothelial cells.
A 15-year-old Morgan x Arab mare previously diagnosed with a pituitary adenoma became ataxic and progressively deteriorated over a 4-week period. The horse was presented recumbant to the Oregon State University Veterinary Teaching Hospital. On physical examination, the mare was in poor body condition with long thick curly hair. The body temperature, heart rate, and respiration rate were within normal ranges. The horse could rise but had proprioceptive deficits primarily of the right front leg. Bilateral horizontal nystagmus was present, and the menace reflex was absent. The mare was treated symptomatically but did not respond to the treatment. The differential diagnosis included acute EPM, brain abscess, and rabies. Because of poor prognosis, the owner elected for euthanasia.
Because the mare was presented with central neurologic deficits and was not vaccinated for rabies, the necropsy examination was confined to the brain and the pituitary gland. The pituitary gland was markedly enlarged (approximately 4 x normal) and on cut section was dark red, revealing 2
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Received for publication August 19, 1996. small (2-3 mm diameter) fluid-filled cystic cavities near its ventral border. One half of the brain was submitted fresh for fluorescent antibody (FA) testing for rabies, and the other half was fixed in 10% neutral buffered form histopathologic examination. The FA test was negative for rabies.
The fixed brain was cut into 4-mm-wide coronal sections. The cut sections revealed many 1-2-mm-wide irregular foci of hemorrhage, which were more prominent in the thalamus 
